Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines

Immuno-Oncology Insights 2024; 5(1), 65–74

DOI: 10.18609/ioi.2024.010

Published: 20 March
Roy de Souza, David Hawke

Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Roy de Souza and David Hawke, co-founders of BreakBio, about innovative strategies for personalized cancer vaccines and the transformative potential of early intervention in cancer.